Suppr超能文献

14-3-3σ通过PARP1和CHK2调节DNA修复和细胞周期,从而促进放射抗性。

14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.

作者信息

Chen Yifan, Li Zhaomin, Dong Zizheng, Beebe Jenny, Yang Ke, Fu Liwu, Zhang Jian-Ting

机构信息

Departments of Pharmacology and Toxicology and IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana.

Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Mol Cancer Res. 2017 Apr;15(4):418-428. doi: 10.1158/1541-7786.MCR-16-0366. Epub 2017 Jan 13.

Abstract

14-3-3σ has been implicated in the development of chemo and radiation resistance and in poor prognosis of multiple human cancers. While it has been postulated that 14-3-3σ contributes to these resistances via inhibiting apoptosis and arresting cells in G-M phase of the cell cycle, the molecular basis of this regulation is currently unknown. In this study, we tested the hypothesis that 14-3-3σ causes resistance to DNA-damaging treatments by enhancing DNA repair in cells arrested in G-M phase following DNA-damaging treatments. We showed that 14-3-3σ contributed to ionizing radiation (IR) resistance by arresting cancer cells in G-M phase following IR and by increasing non-homologous end joining (NHEJ) repair of the IR-induced DNA double strand breaks (DSB). The increased NHEJ repair activity was due to 14-3-3σ-mediated upregulation of PARP1 expression that promoted the recruitment of DNA-PKcs to the DNA damage sites for repair of DSBs. On the other hand, the increased G-M arrest following IR was due to 14-3-3σ-induced Chk2 expression. These findings reveal an important molecular basis of 14-3-3σ function in cancer cell resistance to chemo/radiation therapy and in poor prognosis of human cancers. .

摘要

14-3-3σ与化疗和放疗耐药性的产生以及多种人类癌症的不良预后有关。虽然有人推测14-3-3σ通过抑制细胞凋亡和使细胞停滞在细胞周期的G-M期来导致这些耐药性,但这种调节的分子基础目前尚不清楚。在本研究中,我们检验了这样一个假设:14-3-3σ通过增强DNA损伤处理后停滞在G-M期的细胞中的DNA修复,导致对DNA损伤处理产生抗性。我们发现,14-3-3σ通过在电离辐射(IR)后使癌细胞停滞在G-M期,并通过增加IR诱导的DNA双链断裂(DSB)的非同源末端连接(NHEJ)修复,从而导致对IR产生抗性。NHEJ修复活性的增加是由于14-3-3σ介导的PARP1表达上调,PARP1促进了DNA-PKcs募集到DNA损伤位点以修复DSB。另一方面,IR后G-M期停滞的增加是由于14-3-3σ诱导的Chk2表达。这些发现揭示了14-3-3σ在癌细胞对化疗/放疗的抗性以及人类癌症不良预后中发挥作用的重要分子基础。

相似文献

引用本文的文献

5
ILP-2: A New Bane and Therapeutic Target for Human Cancers.白细胞介素-2:人类癌症的新祸根与治疗靶点。
Front Oncol. 2022 Jun 23;12:922596. doi: 10.3389/fonc.2022.922596. eCollection 2022.

本文引用的文献

6
CHK2 kinase in the DNA damage response and beyond.DNA损伤反应及其他过程中的CHK2激酶
J Mol Cell Biol. 2014 Dec;6(6):442-57. doi: 10.1093/jmcb/mju045. Epub 2014 Nov 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验